Physician profile
Lonna Larger
NPI 1629555321
$3,228.06
in general payments reported to CMS, 2019-2025
17 companies · $605 in 2025
The $605 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $629 · 2022: $517 · 2023: $1,010 · 2024: $467 · 2025: $605.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,082.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,082.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $625.41 | 2021-2025 | |
| Otsuka America Pharmaceutical, INC. | $618.83 | 2021-2025 | Abilify Maintena, Abilify Asimtufii, Rexulti |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $361.15 | 2023-2025 | Caplyta |
| Janssen Pharmaceuticals, INC | $351.88 | 2022-2024 | Invega Sustenna, Invega Trinza, Spravato |
| Axsome Therapeutics, INC. | $281.84 | 2023-2025 | Auvelity, Sunosi |
| Neurocrine Biosciences, INC. | $237.81 | 2021 | |
| Alkermes, INC. | $206.49 | 2021-2023 | Aristada, Aristada Initio |
| E.R. Squibb & Sons, L.L.C. | $123.97 | 2025 | Cobenfy |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $114.46 | 2022 | |
| Lundbeck LLC | $111.89 | 2021-2024 | Abilify Maintena, Rexulti |
| Almatica Pharma LLC | $68.41 | 2023-2024 | Gralise, Loreev Xr |
| Acadia Pharmaceuticals INC | $34.73 | 2022-2023 | Nuplazid |
| Teva Pharmaceuticals USA, INC. | $22.44 | 2023 | Austedo Xr |
| Tris Pharma INC | $20.15 | 2024 | Dyanavel Xr |
| Takeda Pharmaceuticals U.S.A., INC. | $18.44 | 2023 | Trintellix |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neos Therapeutics, LP | $16.16 | 2023 | Adzenys Xr-Odt |
| Sunovion Pharmaceuticals INC. | $14.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lonna Larger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.